Early Withdrawal Exposure and Negative Affect Withdrawal (NAW) Regulation Training for Smoking Cessation
University of Alabama at Birmingham · with National Institute on Drug Abuse (NIDA) · NCT03912194
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 3
- Target enrollment
- 400
- US sites recruiting
- 1
- Study start
- August 1, 2019
- Record last updated
- March 11, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Smoking remains the single most preventable cause of morbidity and mortality in the United States, accounting for approximately half a million deaths every year. The current study will investigate the efficacy and mechanisms of change of a novel smoking cessation intervention. The current study will thus provide essential information regarding a treatment that has the potential to enhance the efficacy of existing smoking cessation interventions, thereby having a beneficial impact on the public health of the United States.
Being studied: cognitive-behavioral withdrawal regulation strategies; relaxation strategies; early withdrawal exposure
Conditions: Tobacco Dependence
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- at least 18 years of age
- smoke at least 5 cigarettes per day
- Expired breath carbon monoxide (CO) reading of at least five parts per million
- report the intention to quit
- reside in the Birmingham area with no plan to relocate outside of the area in the next 6 months
- access to a telephone
Exclusion Criteria
- inability to speak English
- presence of a condition that contraindicates use of the nicotine patch
- presence of conditions that might interfere with compliance with the protocol or greatly complicate treatment
- any acutely life-threatening disease
- concurrent participation in a formal treatment program for smoking cessation
- current use of any pharmacotherapy for smoking cessation
Recruiting US locations
Ryals Public Health Building
Birmingham, AL 35294
Site contact: Peter S Hendricks, PhD · 205.202.1387 · phendricks@uab.edu
Similar studies in Alabama
All smoking & vaping studies in Alabama →- RecruitingHealthy volunteersPhase 2
5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder
Johns Hopkins University
- Location
- Birmingham, AL
- Eligibility basics
- Ages 21+